Vinflunine pharmaceutical composition and method of producing the same and application of the same

A technology of vinflunine and a composition is applied in the field of vinflunine pharmaceutical compositions, which can solve the problems of inability to obtain vinflunine salt freeze-dried preparations, poor stability of medicinal liquid, etc. good stability

Inactive Publication Date: 2008-02-27
QILU PHARMA
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, studies have shown that the vinflunine bitartrate powder injection sample prepared by commonly used lyophilized excipients such as mannitol at a conventional dosage has ...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050]Weigh 205.05 g of hydroxypropyl-β-cyclodextrin, stir and dissolve in 800 ml of sterile water for injection, add 34.175 g of vinflunine bitartrate (equivalent to 25 g of vinflunine) and stir to dissolve it, and measure the pH value of the solution at 3.0- 4.5. Set the volume to 1000ml, add activated carbon for needles, filter, and then filter the filtrate with a 0.22μm microporous membrane, and put it in a sterile vial. Freeze in a freeze-drying cabinet to about -45°C for 2-3 hours, sublimate and dry at -10°C to 0°C for 9 hours, and then dry at 38°C for 5-10 hours, then fill the box with nitrogen, put a stopper on it, and seal it with a gland. Obtain Vinflunine Powder for Injection.

Embodiment 2

[0052] Weigh 136.7g of hydroxypropyl-β-cyclodextrin, 0.6g of citric acid, and 0.6g of sodium citrate, add 800ml of sterile water for injection and stir to dissolve, add 34.175g of vinflunine bitartrate (equivalent to 25g of vinflunine) Stir to dissolve, measure the pH value of the solution to 3.0-4.5, set the volume to 1000ml, add activated carbon for needles, filter, and then filter the filtrate with a 0.22μm microporous membrane, and put it in a sterile vial. Freeze in a freeze-drying cabinet to about -45°C for 2-3 hours, sublimate and dry at -10 to 0°C for 9 hours, and then dry at 38°C for 8-10 hours, take out the box, add a stopper, seal with a gland, and pack for injection. Changchun Flunine Powder Injection.

Embodiment 3

[0054] Weigh 160.0 g of acetyl-γ-cyclodextrin, 0.6 g of citric acid, and 0.8 g of sodium citrate, add 800 ml of sterile water for injection and stir to dissolve, add 34.175 g of vinflunine bitartrate (equivalent to 25 g of vinflunine) and stir Make it dissolve, measure the pH value of the solution to 3.0-4.5, set the volume to 1000ml, add activated carbon for needles, filter, and then filter the filtrate with a 0.22 microporous filter membrane, and put it in a sterile vial. Freeze in a freeze-drying cabinet to about -45°C for 2-3 hours, sublimate and dry at -10 to 0°C for 9 hours, and then dry at 38°C for 5-10 hours, fill the box with nitrogen, put a stopper on it, seal it with a gland, and pack it. .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Molar concentrationaaaaaaaaaa
Login to view more

Abstract

The invention relates to a pharmaceutical composition of Vinflunine, which comprises Vinflunine as the active constituent, pharmaceutically acceptable salts and cyclodextrin, wherein each 1 part of Vinflunine and its pharmaceutically acceptable salt are mixed with a maximum of 0. 5-100 parts by weight ratio of cyclodextrin, and freeze dried injection is prepared. The invention also relates to the process for preparing the composition, and its use in preparing non-stomach administering pharmaceutical products for the treatment of cancer.

Description

technical field [0001] The invention relates to a vinflunine pharmaceutical composition, in particular to a vinflunine freeze-dried powder injection pharmaceutical composition for parenteral administration, a preparation method thereof, and a pharmaceutical application thereof for treating cancer, belonging to the technical field of medicine . Background technique [0002] Vinflunine was originally the latest vinblastine drug screened by French company Pierre Fabre. It is derived from vinorelbine. By inhibiting tubulin polymerization, cell division is stopped in mid-mitosis. It is a cycle-specific anticancer drug. . It can be used in the treatment of non-small cell lung cancer, bladder cancer, breast cancer, mesothelioma, melanoma, kidney cancer and other tumors. [0003] It is reported in the literature that the pharmaceutically acceptable salts of vinflunine are in the form of bitartrate, sulfate and the like. The raw material of vinflunine bitartrate is very unstable a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/475A61K9/19A61K47/40A61P35/00
Inventor 徐先艳杨清敏刘宝明张明会王晶翼
Owner QILU PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap